D. S. Dede Et Al. , "The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Dede, D. S. Et Al. 2010. The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15 .
Dede, D. S., Gumuskaya, B., Guler, G., Onat, D. A., Altundag, K., & Ozisik, Y. Y., (2010). The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen. JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.
Dede, D. Et Al. "The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Dede, D. S. Et Al. "The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15, 2010
Dede, D. S. Et Al. (2010) . "The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.15.
@article{article, author={D. Sener Dede Et Al. }, title={The changes of molecular markers with neoadjuvant dose-dense doxorubicin hydrochloride, cyclophosphamide, and paclitaxel chemotherapy regimen}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2010}